Chubb Limited (CB) Balance Sheet

The balance sheet is clearly strengthening, with total assets rising from $261.6B in Q2 2025 to $281.3B in Q2 2026, a $19.7B increase. This expansion is supported by accelerating premium growth, particularly in Life lines where net written premiums surged 25%, suggesting the strategic pivot toward Asia-Pacific Life is gaining traction. Equity also grew 8.6% year-over-year to $75.4B, indicating strong capital generation that may support future buybacks or M&A.

While the reported invested asset figure of $1,000.0K appears to be a data artifact, the cash flow analysis reveals active reinvestment, with net purchases of $1.6B in Q2 2026. The sustained higher interest rate environment provides a tailwind to net investment income, which may offset potential softening in P&C pricing. Investors should monitor the portfolio's duration and unrealized loss position, as rising rates could create temporary AOCI volatility despite the long-term yield benefit.

The dramatic improvement in loss ratio, combined with a combined ratio of 77.1%, appears to be driven by favorable prior-year reserve releases rather than solely improved underwriting. This raises questions about the sustainability of current earnings quality, as the current accident year loss ratio excluding catastrophes remains the critical metric to watch. Accelerating social inflation in U.S. casualty lines may lead to adverse reserve development if historical loss trends do not reflect current jury award magnitudes, potentially reversing these releases.

The 8.6% year-over-year increase in equity, coupled with a stable debt/equity ratio, suggests a solid capital position that supports both organic growth and shareholder returns. The reported D/E of 0.22% appears anomalously low for a global insurer, likely reflecting parent-company senior debt only, so investors should consider total leverage including insurance liabilities. The strong Q2 2026 earnings beat, with EPS of $7.26 versus $6.34 estimate, indicates robust capital generation that may support continued dividend growth and opportunistic buybacks.

Chubb's liquidity profile appears healthy, with consistent premium collection outpacing claims paid, as evidenced by the OCF/NI ratio consistently above 1.0. Claims paid rose to $10.3B in Q4 2025, the highest in the trailing year, but Q2 2026 saw $8.3B, indicating manageable volatility that may align with catastrophe seasons. The $1.5B returned to shareholders in Q2 2026 was fully covered by operating cash flow of $3.7B, suggesting ample liquidity for both policyholder obligations and capital return.

Forward visibility appears favorable, with the higher-rate environment supporting reinvestment yields on the massive float, which may offset potential softening in P&C pricing. The 25% increase in Life net written premiums, driven by the Cigna Asia-Pacific integration, suggests the strategic pivot is gaining traction and may support a higher valuation multiple if growth persists. However, investors should monitor whether rate increases in P&C lines lag behind loss cost trends, as social inflation could compress margins if pricing does not keep pace.